Comparisons

Zepbound vs Wegovy: Which Weight Loss Medication Works Better in 2026?

If you're researching prescription weight loss medications, you've likely come across two names that keep appearing: Zepbound and Wegovy. Both are FDA-approved, both show impressive results in clinical trials, and both work on similar pathways in your body. So which one actually works better? The answer isn't as simple as picking a winner, but understanding how they differ can help you and your doctor make the right choice for your situation.

What Are Zepbound and Wegovy?

Both Zepbound and Wegovy belong to a class of medications that work on gut hormones to help with weight loss, but they're not identical.

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a hormone your body naturally produces after eating. It was FDA-approved for chronic weight management in 2021 and has been widely prescribed since then.

Zepbound contains tirzepatide, which is actually a dual-acting medication. It activates both GLP-1 and GIP receptors, which is why some doctors call it a "GLP-1 and GIP agonist." Zepbound received FDA approval for weight loss in November 2023, making it the newer option on the market.

Both medications are given as once-weekly injections and work by reducing appetite, slowing digestion, and helping you feel fuller longer.

Comparing Weight Loss Results

When it comes to the numbers, Zepbound has shown slightly higher average weight loss in clinical trials.

In the SURMOUNT-1 trial, people taking the highest dose of Zepbound (15 mg) lost an average of 20.9% of their body weight over 72 weeks. Those on the 10 mg dose lost about 19.5%.

Wegovy's STEP trials showed an average weight loss of 14.9% of body weight over 68 weeks at the 2.4 mg dose.

These are averages, which means individual results vary considerably. Some people respond exceptionally well to one medication but not the other. The difference between 15% and 21% weight loss might sound significant, but both represent substantial, clinically meaningful results that can improve health outcomes.

What About Real-World Results?

Clinical trial conditions don't always match real life. In practice, both medications produce significant weight loss when combined with lifestyle changes. Some patients find one medication easier to tolerate, which matters because staying on the medication consistently is what drives long-term results.

How They Work in Your Body

Understanding the mechanism helps explain why results can differ between people.

Wegovy activates GLP-1 receptors, which sends signals to your brain that you're full, slows how quickly food leaves your stomach, and helps regulate blood sugar. These effects naturally reduce calorie intake without the constant hunger that derails many weight loss attempts.

Zepbound does everything Wegovy does, but adds GIP receptor activation. GIP appears to work synergistically with GLP-1, potentially enhancing fat metabolism and improving how your body processes nutrients. This dual action is likely why Zepbound shows slightly higher average weight loss in studies.

Side Effects: What to Expect

Both medications share similar side effect profiles because they work on overlapping pathways.

The most common side effects include:

Most side effects are mild to moderate and improve as your body adjusts. Starting at a low dose and gradually increasing helps minimize these effects.

Some research suggests Zepbound may cause slightly more gastrointestinal side effects than Wegovy, but this isn't universal. Many patients tolerate one medication better than the other for reasons that aren't entirely clear.

Gender Differences in Side Effects

Women may experience nausea more frequently than men on both medications, particularly during the first month of treatment. Hormonal fluctuations during menstrual cycles can sometimes intensify these effects. If you're noticing a pattern, tracking symptoms alongside your cycle can help your doctor adjust timing or dosage.

Cost Considerations

At list price, both medications are expensive. Wegovy typically costs around $1,300-$1,400 per month, while Zepbound runs $1,000-$1,200 per month without insurance.

Insurance coverage varies widely. Some plans cover one but not the other, and many require prior authorization or documented weight loss program participation. Cost-sharing can still leave patients with $500-$1,000 monthly out-of-pocket expenses.

This is where compounded versions of semaglutide (the active ingredient in Wegovy) and tirzepatide (the active ingredient in Zepbound) have become important access options for many people. Compounded medications contain the same active ingredients but are prepared by specialized pharmacies, typically at a fraction of the brand-name cost.

Which One Is Right for You?

There's no universal "better" choice between these medications. The right one depends on your individual situation.

Zepbound might be preferred if you're looking for potentially higher weight loss numbers and haven't had success with other options. Its dual-action mechanism offers a different approach that some people respond to particularly well.

Wegovy might be the choice if your insurance covers it more favorably, if you prefer a medication with a longer track record, or if you've previously responded well to semaglutide for diabetes management.

Some doctors start with one and switch to the other if results plateau or side effects become problematic. This isn't a one-chance decision.

What About People with Diabetes?

Both medications can help with blood sugar control, even though Zepbound and Wegovy are specifically approved for weight loss. If you have type 2 diabetes, your doctor might consider the closely related medications Ozempic (semaglutide) or Mounjaro (tirzepatide), which are FDA-approved for diabetes management.

From the Ozari Care Team

We see patients succeed on both semaglutide and tirzepatide, and the "better" medication is truly the one you can stay on consistently. Focus on managing side effects during the first month, stay well-hydrated, and don't skip doses trying to speed up results. Gradual, steady dosing increases almost always lead to better tolerance and more sustainable weight loss.

Getting Started with GLP-1 Treatment

Whether you choose Zepbound, Wegovy, or a compounded alternative, working with a medical provider who understands these medications makes a significant difference in your results and experience.

At Ozari Health, we offer compounded semaglutide and tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026